Fujian Haixi Pharmaceuticals Co., Ltd. - H Shares Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Feng Yan, was filed 02 Jul 2026.
Fujian Haixi Pharmaceuticals Co., Ltd. - H Shares: what insiders have been doing
This page follows insider dealings at Fujian Haixi Pharmaceuticals Co., Ltd. - H Shares as filed with HKEX, a company from the Health Care sector. 2 insiders have disclosed 2 filings since 24 October 2025.
Every open-market trade in the period is a purchase: 2 purchases worth €131k, from 2 insiders, and not a single sale. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 2 senior executives among the declarants. At €131k, the purchase published on 30 June 2026 by 康心汕 is the largest of the period.
The most recent open-market purchase was published on 2 July 2026, 129 days ago.
For context, the typical company on the same exchange (median of 1,315 companies) published 4 filings over the same period, against 2 filings here. Looking back to 2026, when coverage begins, insiders filed 2 purchases and no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -11.6%Entry HK$28.35 · Close at T+90 HK$25.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Fujian Haixi Pharmaceuticals Co., Ltd. - H Shares Strong Buy (bullish), based on 2 analysts. Average price target: HK$293.06.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Fujian Haixi Pharmaceuticals Co., Ltd. - H Shares
Fujian Haixi Pharmaceuticals Co., Ltd. is a Chinese pharmaceutical company engaged in the research, development, and production of medications. It is listed on the H-share market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
